Here, we report that miR‐641 level was increased in EGFR‐TKI‐resistant NSCLC, and it can induce erlotinib resistance in NSCLC cells through activation of ERK signaling by direct targeting of NF1. This evidence concerns the gene EGFR and non-small cell lung carcinoma.